ATE549341T1 - Spiroketale - Google Patents

Spiroketale

Info

Publication number
ATE549341T1
ATE549341T1 AT06840408T AT06840408T ATE549341T1 AT E549341 T1 ATE549341 T1 AT E549341T1 AT 06840408 T AT06840408 T AT 06840408T AT 06840408 T AT06840408 T AT 06840408T AT E549341 T1 ATE549341 T1 AT E549341T1
Authority
AT
Austria
Prior art keywords
infections
useful
methods
spiroketals
spiroketal compounds
Prior art date
Application number
AT06840408T
Other languages
English (en)
Inventor
Paul Warren Reddell
Victoria Anne Gordon
Original Assignee
Ecobiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005907277A external-priority patent/AU2005907277A0/en
Application filed by Ecobiotics Ltd filed Critical Ecobiotics Ltd
Application granted granted Critical
Publication of ATE549341T1 publication Critical patent/ATE549341T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT06840408T 2005-12-23 2006-12-22 Spiroketale ATE549341T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005907277A AU2005907277A0 (en) 2005-12-23 Spiroketals
PCT/AU2006/002000 WO2007070984A1 (en) 2005-12-23 2006-12-22 Spiroketals

Publications (1)

Publication Number Publication Date
ATE549341T1 true ATE549341T1 (de) 2012-03-15

Family

ID=38188191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06840408T ATE549341T1 (de) 2005-12-23 2006-12-22 Spiroketale

Country Status (12)

Country Link
US (4) US8013012B2 (de)
EP (1) EP1971608B1 (de)
JP (2) JP5324922B2 (de)
CN (1) CN101389632B (de)
AT (1) ATE549341T1 (de)
AU (1) AU2006326871B2 (de)
CA (1) CA2634468C (de)
DK (1) DK1971608T3 (de)
ES (1) ES2386038T3 (de)
NZ (1) NZ569403A (de)
PT (1) PT1971608E (de)
WO (1) WO2007070984A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1971608T3 (da) * 2005-12-23 2012-07-02 Ecobiotics Ltd Spiroketaler
TW201011043A (en) 2008-06-20 2010-03-16 Chugai Pharmaceutical Co Ltd Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
TWI481422B (zh) * 2010-02-26 2015-04-21 高雄醫學大學 抑制皮膚色素沉著之組合物及其用途
JP5733087B2 (ja) 2011-07-29 2015-06-10 信越化学工業株式会社 室温湿気増粘型熱伝導性シリコーングリース組成物
KR102359214B1 (ko) 2014-04-04 2022-02-07 델 마 파마슈티컬스 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체
CN112094699B (zh) * 2020-09-27 2023-03-28 广西壮族自治区林业科学研究院 一种樟树纯露的提取方法
CN113875598B (zh) * 2021-11-19 2022-10-18 宜宾学院 一种诱导半夏愈伤组织的方法及其专用培养基
CN117137896A (zh) * 2023-09-19 2023-12-01 复旦大学 依他尼酸在制备治疗肺炎药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000514A2 (en) * 1998-06-29 2000-01-06 Parker Hughes Institute Synthetic spiroketal pyranes as potent anti-cancer agents
US6335364B1 (en) * 1998-06-29 2002-01-01 Parker Hughes Institute Synthetic spiroketal pyranes as potent anti-cancer agents
US6069238A (en) * 1998-09-30 2000-05-30 Eli Lilly And Company Spirocyclic C-glycosides
JP4168495B2 (ja) * 1998-10-05 2008-10-22 三菱化学株式会社 ４級アンモニウム塩の製造方法
DK1971608T3 (da) * 2005-12-23 2012-07-02 Ecobiotics Ltd Spiroketaler

Also Published As

Publication number Publication date
US8921414B2 (en) 2014-12-30
AU2006326871B2 (en) 2011-09-15
CA2634468A1 (en) 2007-06-28
US20140286938A1 (en) 2014-09-25
WO2007070984A1 (en) 2007-06-28
EP1971608A4 (de) 2010-02-24
EP1971608B1 (de) 2012-03-14
US8466194B2 (en) 2013-06-18
JP2009520698A (ja) 2009-05-28
ES2386038T3 (es) 2012-08-07
DK1971608T3 (da) 2012-07-02
JP5324922B2 (ja) 2013-10-23
JP2013177393A (ja) 2013-09-09
NZ569403A (en) 2010-10-29
EP1971608A1 (de) 2008-09-24
US8013012B2 (en) 2011-09-06
US20120034216A1 (en) 2012-02-09
CN101389632A (zh) 2009-03-18
CA2634468C (en) 2014-10-07
PT1971608E (pt) 2012-06-21
US20130324596A1 (en) 2013-12-05
AU2006326871A1 (en) 2007-06-28
US20090082428A1 (en) 2009-03-26
US8680141B2 (en) 2014-03-25
CN101389632B (zh) 2013-02-06

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
EP2185514A4 (de) Vinylarylderivate für mit entzündungen und dem immunsystem in zusammenhang stehende anwendungen
SG170813A1 (en) New compounds
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
WO2008048991A3 (en) Organic compounds
CY1110230T1 (el) Αναστολεις γυρασης και χρησεις αυτων
MY151551A (en) Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors
MY177564A (en) Anti-nr10 antibody and use thereof
EP2452935A3 (de) Tetracyxlin-Derivate zur Behandlung bakterieller, viraler und parasitärer Infektionen
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
AU2006254902A8 (en) Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
MX2009009290A (es) Compuestos activos en ppar.
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
WO2007095638A3 (en) Boron-containing small molecules as anti-inflammatory agents
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
WO2005072826A3 (en) Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
MX2009012767A (es) Metodos de tratamiento de infecciones fungicas.
WO2006099131A3 (en) Elasmobranch-repelling magnets and methods of use
CY1109992T1 (el) Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
BRPI0509660A (pt) compostos de beta-carbolina de utilidade no tratamento de doenças inflamatórias
MY154715A (en) Anti-nr10 antibody and use thereof
DK1971608T3 (da) Spiroketaler
EA200800713A1 (ru) Аморфные твёрдые дисперсии
DE602005005787D1 (de) Indolylmaleimidderivate